Intuitive Surgical Inc. has reported preliminary results for the fourth quarter and full year 2024, showcasing strong financial performance. The company's Q4 revenue reached $2.41 billion, marking a 25% increase year-over-year, while full-year revenue was $8.35 billion, up 17% from the previous year. The number of da Vinci procedures increased by 18% in Q4 and 17% for the full year, totaling approximately 2.68 million procedures. Additionally, Intuitive Surgical placed 493 systems in Q4, a 19% rise year-over-year, and 1,526 systems for the full year. CEO Gary Guthart emphasized the robust adoption of the da Vinci system. The company's stock experienced a significant breakout, surpassing the $560 mark, following the announcement of these results. Intuitive Surgical's performance has been positively received by investors, with the stock breaking out after exceeding forecasts. The integration of Surgical Sciences' simulation solutions into the new da Vinci 5 surgical robots is also seen as a positive development for Surgical Science, contributing to a two-digit increase in its stock price.